股票代码：******
网站地图
The company implemented shareholding reform in December 2017. In Phase I, the company has built a biopharmaceutical production workshop meeting GMP standards, the largest laboratory animal center in Jiangxi Province, a provincial enterprise technology center, and an immune technology research and development center meeting GMP requirements.
Add:
Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, P.R.China.
Telephone:
Email:
Pharmacovigilance collection mailbox:
Pharmacovigilance telephone:
Microofficial website
0796-8403905
E-mail 